Clinical Trial Update: A Registry for Participants With Chronic Hypoparathyroidism

View source ↗

Summary

Takeda is updating a registry for participants with chronic hypoparathyroidism; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Snippet

Sponsor: Takeda | Conditions: Hypoparathyroidism | Status: ACTIVE_NOT_RECRUITING